Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Meningococcal disease, polysaccharide vaccines

Meningococcal vaccine (quadrivalent polysaccharide for serogroups A, C, Y, and W-135)—Consider vaccination for persons with medical indications adults with terminal complement component deficiencies, with anatomic or functional asplenia. Other indications travelers to countries in which disease is hyperendemic or epidemic ("meningitis belt" of sub-Saharan Africa, Mecca, Saudi Arabia for Hajj). Revaccination at 3-5 years may be indicated for persons at high risk for infection (e.g., persons residing in areas in which disease is epidemic). [Pg.2253]

The pertussis and antil3miphoc3l e preparations are used in passive immunization. Both the mumps vaccine and BCG (used for tuberculosis) are used in active immunization, but they are live organisms. Pneumococcal vaccine is a polysaccharide recommended for individuals at high risk for pneumococcal disease. The Haemophilus and meningococcal vaccines (not listed) are also polysaccharides. The answer is (E). [Pg.542]

See other pages where Meningococcal disease, polysaccharide vaccines is mentioned: [Pg.1042]    [Pg.2253]    [Pg.1245]    [Pg.581]    [Pg.1406]    [Pg.194]    [Pg.568]    [Pg.2251]    [Pg.150]    [Pg.2239]    [Pg.2239]    [Pg.2239]    [Pg.149]    [Pg.267]    [Pg.139]    [Pg.174]   
See also in sourсe #XX -- [ Pg.193 , Pg.194 ]

See also in sourсe #XX -- [ Pg.41 , Pg.193 , Pg.194 ]



SEARCH



Meningococcal disease, polysaccharide

Meningococcal polysaccharides

Meningococcal vaccine

Vaccinations meningococcal

© 2024 chempedia.info